Key facts
- Matrix Capital Management Company, LP filed SCHEDULE 13D/A for Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA).
- Disclosed ownership: 0%.
- Date of event: 07 May 2026.
Matrix Capital Management Company, LP - 07 May 2026 SCHEDULE 13D/A Report for Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA)
- Filing Manager
- Matrix Capital Management Company, LP
- Reporting Manager
- Matrix Capital Management Company LP
- Symbol
- AURA
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13D/A
- Filing time
- 11 May 2026, 16:15:07 UTC
- Date of event
- 07 May 2026
- Previous filing
- 19 May 2025
- SEC
- View on sec.gov
Key filing fact
Matrix Capital Management Company, LP disclosed 0% ownership in Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA) on 07 May 2026.
Change
- Previous schedule filing date: 19 May 2025.
- Current filing was accepted on 11 May 2026, 16:15.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Matrix Capital Management Company LP | 0% | 0 | 0 | 0 | /s/ David E. Goel | David E. Goel, Managing General Partner | 0001410830 |
| David E. Goel | 0% | 0 | 0 | 0 | /s/ David E. Goel | David E. Goel, Individually |
CIK / CUSIP context first